The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Bank of America Cuts HSBC And Raises Croda

Mon, 07th Dec 2020 09:53

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

----------

FTSE 100

----------

BANK OF AMERICA CUTS HSBC TO 'UNDERPERFORM' ('NEUTRAL') - PRICE TARGET 426 PENCE

----------

BOFA RAISES CRODA INTERNATIONAL TO 'BUY' ('NEUTRAL') - TARGET 6,800 (6,500) PENCE

----------

MORGAN STANLEY CUTS CRODA INTERNATIONAL TARGET TO 6,500 (6,600) PENCE - 'OVERWEIGHT'

----------

UBS RAISES GLENCORE PRICE TARGET TO 300 (280) PENCE - 'BUY'

----------

UBS RAISES BURBERRY PRICE TARGET TO 1,164 (1,140) PENCE - 'SELL'

----------

UBS RAISES BERKELEY GROUP PRICE TARGET TO 5,475 (5,050) PENCE - 'BUY'

----------

BERNSTEIN RAISES NEXT PRICE TARGET TO 6,700 (5,000) PENCE - 'MARKET-PERFORM'

----------

CREDIT SUISSE CUTS KINGFISHER PRICE TARGET TO 345 (350) PENCE - 'OUTPERFORM'

----------

CREDIT SUISSE RAISES FERGUSON PRICE TARGET TO 8,898 (6,181) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS RAISES VODAFONE PRICE TARGET TO 165 (155) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES FLUTTER PRICE TARGET TO 14,800 (12,387) PENCE - 'HOLD'

----------

MORGAN STANLEY RAISES ASTRAZENECA TO 'OVERWEIGHT' ('EQUAL WEIGHT') - PRICE TARGET 9900 (9400) PENCE

----------

BARCLAYS RAISES JOHNSON MATTHEY TARGET TO 2640 (2450) PENCE - 'EQUAL WEIGHT'

----------

BARCLAYS RAISES GLENCORE PRICE TARGET TO 215 (210) PENCE - 'OVERWEIGHT'

BARCLAYS RAISES AB FOODS PRICE TARGET TO 2,700 (2,280) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE RAISES SSE PRICE TARGET TO 1,425 (1,300) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES SPIRAX-SARCO PRICE TARGET TO 10,300 (9,800) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES HALMA PRICE TARGET TO 1,900 (1,800) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN RAISES ASHTEAD GROUP PRICE TARGET TO 3,300 (3,100) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES GLENCORE PRICE TARGET TO 290 (275) PENCE - 'BUY'

----------

FTSE 250

----------

BOFA RAISES SYNTHOMER PRICE TARGET TO 440 (400) PENCE - 'NEUTRAL'

----------

HSBC CUTS WIZZ AIR TO 'HOLD' ('BUY') - PRICE TARGET 5,000 PENCE

----------

RBC RAISES WEIR GROUP PRICE TARGET TO 2,000 (1,800) PENCE - 'OUTPERFORM'

----------

GOLDMAN SACHS RAISES MICRO FOCUS TO 'BUY' ('NEUTRAL') - TARGET 650 (335) PENCE

----------

JPMORGAN RAISES SPECTRIS PRICE TARGET TO 2,600 (2,500) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS ROTORK TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 310 PENCE

----------

RBC CUTS PARAGON GROUP PRICE TARGET TO 430 (470) PENCE - 'SECTOR PERFORM'

---------

OTHER MAIN MARKET AND AIM

----------

UBS RAISES RYANAIR PRICE TARGET TO 15.65 (14.70) EUR - 'NEUTRAL'

----------

GOLDMAN RAISES LEARNING TECHNOLOGIES GROUP TARGET TO 118.3 (114.3) PENCE - 'SELL'

----------

BOFA RAISES ELEMENTIS PRICE TARGET TO 105 (70) PENCE - 'UNDERPERFORM'

----------

BERENBERG RAISES DISCOVERIE PRICE TARGET TO 660 (590) PENCE - 'BUY'

----------

BERENBERG RAISES CERES POWER PRICE TARGET TO 1060 (790) PENCE - 'BUY'

----------

BERENBERG RAISES LEARNING TECHNOLOGIES TARGET TO 200 (190) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES SENIOR PRICE TARGET TO 105 (65) PENCE - 'OUTPERFORM'

----------

BERENBERG RAISES PENDRAGON TO 'BUY' ('HOLD') - TARGET 25 (8) PENCE

----------

RBC CUTS SUPERDRY TO 'SECTOR PERFORM' ('OUTPERFORM') - TARGET 300 (200) PENCE

----------

BOFA RAISES BANK OF IRELAND PRICE TARGET TO 3,40 (2,60) EUR - 'BUY'

----------

BARCLAYS RAISES BANK OF IRELAND PRICE TARGET TO 3,60 (2,50) EUR - 'OVERWEIGHT'

----------

BARCLAYS CUTS AIB TO 'EQUAL WEIGHT' ('OVERWEIGHT') - TARGET 1,85 (1,35) EUR

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.